Home › Therapeutic areas › Dermatology › Atopic Dermatitis

Atopic Dermatitis (14 companies)

Companies with an active program in Atopic Dermatitis.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ACRS Aclaris Therapeutics DermatologyGI/Hepatology+1 Rare 3 Phase 2 $536M 7
ALDX Aldeyra Therapeutics DermatologyOncology+1 1 NDA Submitted $41.9M 5
APGE Apogee Therapeutics DermatologyGI/Hepatology+1 Rare 3 Phase 2 — 9
RCUS Arcus Biosciences DermatologyImmunology+1 1 Phase 3 $2.36B 8
CLDX Celldex Therapeutics DermatologyImmunology+1 1 Phase 3 $2.20B 6
CRVS Corvus Pharmaceuticals DermatologyOncology+1 Rare 1 Phase 3 $858M 7
ENTA Enanta Pharmaceuticals DermatologyImmunology+2 1 Approved $253M 8
EVMN Evommune DermatologyImmunology+1 1 Phase 2 $290M 6
IMCR Immunocore DermatologyInfectious Disease+2 1 Approved $1.44B 12
KYMR Kymera Therapeutics DermatologyImmunology+1 Rare 1 Phase 2 $10.4B 5
NKTR Nektar Therapeutics DermatologyImmunology+2 1 Phase 3 $1.23B 11
TTRX Turn Therapeutics DermatologyInfectious Disease Rare 1 Phase 2 $261M 4
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 1 Approved $230M 27
ZURA Zura Bio DermatologyImmunology Rare 1 Phase 2 $99.7M 4